Log in
Enquire now
‌

US Patent 11572339 Amphetamine carbamate compounds and methods

Patent 11572339 was granted and assigned to Noven Pharmaceuticals on February, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Noven Pharmaceuticals
Noven Pharmaceuticals
Current Assignee
Noven Pharmaceuticals
Noven Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11572339
Date of Patent
February 7, 2023
Patent Application Number
17569872
Date Filed
January 6, 2022
Patent Citations
‌
US Patent 10406115 Pressure-sensitive adhesives for transdermal drug delivery
‌
US Patent 10004696 Compositions and methods for transdermal delivery of amphetamine
‌
US Patent 10231938 Transdermal drug delivery device including an occlusive backing
‌
US Patent 10406116 Pressure-sensitive adhesives for transdermal drug delivery
Patent Citations Received
‌
US Patent 11976026 Amphetamine carbamate compounds and methods
0
Patent Primary Examiner
‌
Daniel S Larkin

Described herein are the amphetamine-related compounds amphetamine carbamate (amphetammonium-amphetacarbamate) and amphetacarbamate, methods of making them, methods for detecting or quantitatively determining the amount of amphetacarbamate or amphetamine carbamate in a compositions, and ion chromatography columns useful in such methods.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11572339 Amphetamine carbamate compounds and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.